◀ Back to NOS1
NOS1 — WDR61
Text-mined interactions from Literome
Fabi et al., Br J Pharmacol 2001
:
1. To further investigate into the mechanisms of PAF induced cardiopulmonary actions, we examined the
effects of the nitric oxide synthase (NOS) inhibitor L-N ( omega ) -nitro-L-arginine ( L-NNA ), of the specific cyclooxygenase-2 (COX-2) inhibitor NS 398, and of the combined presence of both COX and
NOS inhibitors on the
PAF responses in the heart lung preparation of guinea-pig ( HLP )
Qu et al., Crit Care Med 2005
(Intestinal Diseases) :
We reported previously that
neuronal nitric oxide synthase (nNOS) is the predominant NOS in rat small intestine and is
down-regulated by
platelet activating factor (PAF) ... In part 2, tetrahydrobiopterin protected against
PAF induced intestinal necrosis, hypoperfusion, neutrophil influx, and
NOS suppression
De Kimpe et al., Br J Pharmacol 1995
(Acute Kidney Injury...) :
6. Thus, the intracellular release of
PAF contributes to the circulatory and renal failure and induction of
nitric oxide synthase elicited by LTA in anaesthetized rats
Chaud et al., Prostaglandins Leukot Essent Fatty Acids 1998
:
On the other hand,
NOS activity was detected in uterine strips and could be
stimulated by
PAF